Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.
about
Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesTheranostic Imaging of Yttrium-90Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization.Radioembolization of hepatic tumorsPhase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancerDetermination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization (90)Y PET.RETRACTED ARTICLE: A Case Series of Four Patients With Clinically Significant Radiomicrosphere Pneumonitis After Yttrium-90 Radioembolization from the Perspective of Lung Dosimetry.A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma.Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy.Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyHepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma.Experimental and Simulation Analysis of Radiation of the Beta Emitting Sources in a Magnetic Field.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheresNovel implications in the treatment of hepatocellular carcinoma.Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization.The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?Tumor vascular disruption using various radiation types.Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer.Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization.Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.A method for energy window optimization for quantitative tasks that includes the effects of model-mismatch on bias: application to Y-90 bremsstrahlung SPECT imaging.Optimization of energy window for 90Y bremsstrahlung SPECT imaging for detection tasks using the ideal observer with model-mismatch.A collimator optimization method for quantitative imaging: application to Y-90 bremsstrahlung SPECT.Impact of respiratory motion and acquisition settings on SPECT liver dosimetry for radioembolization.Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.(210)Po microsphere radiological design for tumor vascular disruptionDevelopment and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method.Safety of repeated yttrium-90 radioembolization.Determining the effects of microsphere and surrounding material composition on (90)Y dose kernels using egsnrc and mcnp5.Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.Predictive SIRT dosimetry based on a territorial model.
P2860
Q27007847-4DE54AB4-7EC9-4BA6-927A-90840C6834F7Q27023616-E0177E7C-60A3-4577-AB4C-CB12E7892BACQ28083044-A2BED022-F9A5-4AB8-BD70-72FDE1DFE64AQ30151984-03643FC4-0E8E-4102-84A5-D822B9F18346Q33410714-93CF07BF-C3E7-4015-B147-AD224634E162Q33820777-AF2B5166-AB50-4C6C-9E02-DEE54465929EQ33918145-9AAD5416-4548-4732-B53D-0A4058EF2FA2Q34330202-815A8E4C-B2F2-45D8-9A9F-7ADA4180FDA0Q35162702-1FEA07B9-1E95-490A-BB37-9C0460D2ED00Q35528970-F592A5FB-0D05-4671-8A9C-8F025B07FD33Q35962164-280A6B2B-2AEF-4708-B9D3-7799D9C9E169Q36157591-FE1F32D9-35B4-4112-9505-61BDFFA662CBQ36194191-B1B9992E-E87D-42A3-8B75-CF9FBD12D22FQ36352452-62E87A53-4A21-4BA0-AEB0-F5830AA6E8D1Q36396455-799FE108-1977-481B-8356-4D2C8F349A52Q36405092-5AED9E71-F649-4257-A102-9DF7E123F757Q36899620-BF5789CC-E45E-4637-8CE4-36CC50922F80Q37042948-1183CD3C-FF22-4443-910D-08A1B57FD155Q37071558-698F71F8-1BE7-4247-9981-C1D6B16A6A41Q37542835-CA4EB59F-EA2A-4B76-8C74-9CD77411E4ACQ38084139-812C45D4-026D-4F78-9786-0010575D9DCAQ38219225-7D1B0C96-9BA6-4D45-A875-EBC512E7AAD4Q38398444-EBA9FBEF-5088-42A6-850D-A8328C55E3DFQ38538075-68E6B2E3-2776-4520-8ABD-06C55534ACA0Q38551055-BA369E93-1611-45B9-A33C-3847F00A1F9BQ38619331-6CED475C-70D0-447F-99F3-4A6051001C49Q39248616-09A11970-B184-4E6D-940B-F51D2E8A741CQ39310997-60F64828-9FF6-4262-91CA-4F7BA36B6261Q39637887-CBDE8F09-45A1-4EAA-A7B5-498BAEC014D6Q40036704-2F32244F-5D50-4342-BC9E-52599BE0A341Q40114153-5F8F9338-EAA9-4E7F-BDD4-69E3878898E3Q40129675-4C778F32-CF69-4417-981E-85C0464B2E2AQ40489091-FFB4B910-EF58-4089-8587-56467C05FB20Q41017630-E36D1B8A-8D91-4AAC-9624-C45F4537ED91Q41881660-C4E11FA5-553D-448D-A06F-1DDCABAA8B90Q42138765-CD33AE65-3C41-42A3-93B8-13711C55C362Q44200845-4B94DDCC-1735-4C95-B17D-245EEAFBB671Q44936225-E9DB6EAA-E0AA-460D-9844-17BA06038298Q46657713-3F52B10D-FB71-433E-9C94-9802D345E90DQ47171915-B779A682-D72C-4A17-9726-0C84794F76DE
P2860
Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Recommendations of the America ...... tment of hepatic malignancies.
@en
Recommendations of the America ...... tment of hepatic malignancies.
@nl
type
label
Recommendations of the America ...... tment of hepatic malignancies.
@en
Recommendations of the America ...... tment of hepatic malignancies.
@nl
prefLabel
Recommendations of the America ...... tment of hepatic malignancies.
@en
Recommendations of the America ...... tment of hepatic malignancies.
@nl
P2093
P2860
P356
P1433
P1476
Recommendations of the America ...... tment of hepatic malignancies.
@en
P2093
American Association of Physicists in Medicine
Andrew S Kennedy
Bruce R Thomadsen
James Halama
Jeffery T Cessna
Larry A DeWerd
Lawrence E Williams
Mehrdad Sarfaraz
Michael G Stabin
Reed Selwyn
P2860
P304
P356
10.1118/1.3608909
P407
P577
2011-08-01T00:00:00Z